EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effect of Pemafibrate on the Lipid Profile, Liver Function, and Liver Fibrosis Among Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

Mona Hassan, Hasan Al-Obaidi, Megan Karrick, Nooraldin Merza, Yusuf Nawras, Omar Saab, Ahmed Dheyaa Al-Obaidi, Fatima Merza, Hashim Talib Hashim, Khalid Al Zubaidi, Daniah Al-Sabbagh, Rand Matbachi und 7 weitere

Gastroenterology Research · 2024-08 · 17 (4) · 159-174

DOI: 10.14740/gr1750 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gastroenterology Research, 2024-08. Verfasst von Mona Hassan und 18 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology Department, The University of Toledo, Toledo, OH, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Lipid profileLiver fibrosisLiver stiffnessMASHMASLDPPARPemafibrate

Autor:innen und Institutionen

  • Gastroenterology and Hepatology Department, The University of Toledo, Toledo, OH, USA.
  • Internal Medicine Department, Jamaica Hospital Medicine Center, Queens, NY, USA.
  • University of Toledo College of Medicine and Life Science, Toledo, OH, USA.
  • Internal Medicine Department, Cleveland Clinic, Cleveland, OH, USA.
  • Internal Medicine Department, College of Medicine, University of Baghdad, Baghdad, Iraq.
  • Department of Health and Human Services, University of Michigan, Dearborn, MI, USA.

Zitieren

APA

Hassan, M., Al-Obaidi, H., Karrick, M., Merza, N., Nawras, Y., Saab, O., Al-Obaidi, A. D., Merza, F., Hashim, H. T., Al Zubaidi, K., Al-Sabbagh, D., Matbachi, R., Noori, Z., Amatul-Raheem, H., Mansur, S., Al Najafi, O., Algodi, M., Al Hamdany, T., & Kobeissy, A. (2024). Effect of Pemafibrate on the Lipid Profile, Liver Function, and Liver Fibrosis Among Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. Gastroenterology Research, 17(4), 159-174. https://doi.org/10.14740/gr1750

Vancouver

Hassan M, Al-Obaidi H, Karrick M, Merza N, Nawras Y, Saab O, et al. Effect of Pemafibrate on the Lipid Profile, Liver Function, and Liver Fibrosis Among Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. Gastroenterology Research. 2024;17(4):159-174. doi:10.14740/gr1750

BibTeX
@article{Hassan2024,
  author = {Hassan, Mona and Al-Obaidi, Hasan and Karrick, Megan and Merza, Nooraldin and Nawras, Yusuf and Saab, Omar and Al-Obaidi, Ahmed Dheyaa and Merza, Fatima and Hashim, Hashim Talib and Al Zubaidi, Khalid and Al-Sabbagh, Daniah and Matbachi, Rand and Noori, Zainab and Amatul-Raheem, Hajra and Mansur, Sarmad and Al Najafi, Omer and Algodi, Marwah and Al Hamdany, Tamarah and Kobeissy, Abdallah},
  title = {Effect of Pemafibrate on the Lipid Profile, Liver Function, and Liver Fibrosis Among Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease},
  journal = {Gastroenterology Research},
  year = {2024},
  volume = {17},
  number = {4},
  pages = {159--174},
  doi = {10.14740/gr1750}
}
Kostenlos starten →